Adma Biologics Inc (ADMA)

Finanzdaten der Adma Biologics Inc-Aktie (ADMA)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	8.65%124.40	114.49	139.16	134.22	121.98
Cost Of Revenue	12.97%38.12	33.74	50.35	58.60	54.76
Gross Profit	6.84%86.28	80.75	88.82	75.63	67.23
	50.53%33.83	22.48	26.07	24.61	24.43
Selling, General, and Administrative	0.02%26.74	26.74	23.51	21.78	22.21
Research and Development	131.57%6.01	2.60	1.38	1.53	1.03
Other Operating Expenses	3.39%1.03	1.06	1.13	1.27	1.15
Depreciation and Amortization	3.15%1.78	1.84	2.05	2.02	2.06
Operating Income/Loss	10.00%52.45	58.27	62.75	51.01	42.80
Nonoperating Income/Loss	92.50%-2.21	-1.15	-1.16	-3.50	-2.70
Income/Loss From Continuing Operations Before Tax	12.06%50.24	57.13	61.60	47.52	40.10
Income Tax Expense/Benefit, Deferred	99.91%0.00	3.29	1.17	4.80	1.62
Income Tax Expense/Benefit	5.22%12.42	11.80	12.22	11.09	5.88
	16.56%37.82	45.33	49.38	36.43	34.22
Attributable To Parent	16.56%37.82	45.33	49.38	36.43	34.22
Available To Common Stockholders, Basic	16.56%37.82	45.33	49.38	36.43	34.22
Basic Average Shares	3.32%228.23	236.07	-0.11	238.60	241.49
Diluted Average Shares	4.01%230.34	239.96	-0.59	244.66	248.61
Basic Earnings Per Share	10.53%0.17	0.19	0.21	0.15	0.14
Diluted Earnings Per Share	15.79%0.16	0.19	0.20	0.15	0.14